Bundle Evaluation in Extra Renal Epuration, Incidence of Thrombosis

Completed

• Conditions: Adults Receiving Renal Replacement Therapy
• Interventions: Other: renal replacement therapy

• Registration Number: NCT01560364
• Lead Sponsor: University Hospital, Clermont-Ferrand

Brief Summary

This is a prospective observational clinical multicentric study in ICU with acute renal failure requiring renal replacement therapy.

Detailed Description

Prospective before / after observational clinical multicentric study on ICU acute kidney injury during renal replacement therapy. Evaluation of incidence and exposure to hemofilter clotting.

The after phase will consist in medical measures (help for prescription) and paramedical measures (stop the filtration flow during the patient's mobilization).

Study Timeline

• Study Start: 2011-05
• Study First Submitted: 2011-10-17
• Study First Submitted QC: 2012-03-20
• Study First Posted: 2012-03-22
• Primary Completion: 2012-08
• Study Completion: 2012-08
• Status Verified: 2014-11
• Last Update Submitted: 2014-11-28
• Last Update Posted: 2014-12-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• Adult (age > 18 years)
• Renal replacement therapy (continuous veino-veinous hemofiltration or continuous veino-veinous hemodiafiltration)
• Consent of patients

Exclusion Criteria

• Use citrate anticoagulation
• Age below 18 years

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Hemofilter	renal replacement therapy	-

Primary Outcome Measures

Name	Time	Method
Hemofilter lifetime	at day 1

Secondary Outcome Measures

Name	Time	Method
hemofiltration duration	at day 1
Hemofilter clotting risk factors	at day 1
down time value	at day 1

Trial Locations

Locations (1)

CHU Clermont-Ferrand; 🇫🇷 Clermont-Ferrand, France